D-4F, an apolipoprotein A-I mimetic peptide, promotes cholesterol efflux from macrophages via ATP-binding cassette transporter A1

Tohoku Journal of Experimental Medicine

Volumn 220, Issue 3, 2010, Pages 223-228

  Xie, Qiong ^a   Zhao, Shui ping ^a   Li, Feng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apolipoprotein A I mimetic peptide; ATP binding cassette transporter A1; Cholesterol efflux; Cyclic AMP; Macrophage

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CYCLIC AMP; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PEPTIDE; PEPTIDE D 4F; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; LIPID METABOLISM; MACROPHAGE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL LINE; CHOLESTEROL; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOQUINOLINES; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; PROTEIN KINASE INHIBITORS; SULFONAMIDES;

EID: 77950410559     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.220.223     Document Type: Article

References (17)

1. Cavelier, C., Lorenzi, I., Rohrer, L. & von Eckardstein, A. (2006) Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. Biochim. Biophys. Acta, 1761, 655-666.
2. Datta, G., Chaddha, M., Garber, D.W., Chung, B.H., Tytler, E.M., Dashti, N., Bradley, W.A., Gianturco, S.H. & Anantharamaiah, G.M. (2000) The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL in fibroblasts. Biochemistry, 39, 213-220.
3. Haidar, B., Denis, M., Krimbou, L., Marcil, M. & Genest, Jr. J. (2002) cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J. Lipid Res., 43, 2087-2094.
4. Haidar, B., Denis, M., Marcil, M., Krimbou, L. & Genest, Jr. J. (2004) Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. J. Biol. Chem., 279, 9963-9969.
5. Marcil, M., Bissonnette, R., Vincent, J., Krimbou, L. & Genest, J. (2003) Cellular phospholipid and cholesterol efflux in highdensity lipoprotein deficiency. Circulation, 107, 1366-1371.
6. Navab, M., Anantharamaiah, G.M., Reddy, S.T., Hama, S., Hough, G., Grijalva, V.R., Wagner, A.C., Frank, J.S., Datta, G., Garber, D. & Fogelman, A.M. (2004a) Oral D-4F causes formation of pre-beta high-density lipoprotein and improves highdensity lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation, 109, 3215-3220.
7. Navab, M., Anantharamaiah, G.M., Reddy, S.T., Hama, S., Hough, G., Grijalva, V.R., Yu, N., Ansell, B.J., Datta, G., Garber, D.W. & Fogelman A.M. (2005) Apolipoprotein A-I mimetic peptides. Arterioscler. Thromb. Vasc. Biol., 25, 1325-1331.
8. Navab, M., Anantharamaiah, G.M., Reddy, S.T., Van Lenten, B.J., Ansell, B.J., Fonarow, G.C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., Berliner, J.A., Lusis, A.J. & Fogelman, A.M. (2004b) The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J. Lipid Res., 45, 993-1007.
9. Navab, M., Anantharamaiah, G.M., Reddy, S.T., Van Lenten, B.J., Buga, G.M. & Fogelman, A.M. (2007) Peptide Mimetics of Apolipoproteins Improve HDL Function. J. Clin. Lipidol., 1, 142-147.
10. Navab, M., Anantharamaiah, G.M., Reddy, S.T., Van Lenten, B.J., Datta, G., Garber, D. & Fogelman, A.M. (2006) Potential clinical utility of high-density lipoprotein-mimetic peptides. Curr. Opin. Lipidol., 17, 440-444.
11. Ohashi, R., Mu, H., Wang, X., Yao, Q. & Chen, C. (2005) Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM, 98, 845-856.
12. Oram, J.F., Lawn, R.M., Garvin, M.R. & Wade, D.P. (2000) ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem., 275, 34508-34511.
13. Rader, D.J., Alexander, E.T., Weibel, G.L., Billheimer, J. & Rothblat, G.H. (2009) The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J. Lipid Res., 50 Suppl, S189-S194.
14. Santamarina-Fojo, S., Peterson, K., Knapper, C., Qiu, Y., Freeman, L., Cheng, J.F., Osorio, J., Remaley, A., Yang, X.P., Haudenschild, C., Prades, C., Chimini, G., Blackmon, E., Francois, T., Duverger, N., Rubin, E.M., Rosier, M., Denefle, P., Fredrickson, D.S. & Brewer, H.B.Jr. (2000) Completegenomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc. Natl. Acad. Sci. USA, 97, 7987-7992.
15. Tang, C., Vaughan, A.M., Anantharamaiah, G.M. & Oram, J.F. (2006) Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1. J. Lipid Res., 47, 107-114.
16. Tang, C., Vaughan, A.M. & Oram, J.F. (2004) Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J. Biol. Chem., 279, 7622-7628.
17. Yokoyama, S. (2000) Release of cellular cholesterol: molecular mechanism for cholesterol homeostasis in cells and in the body. Biochim. Biophys. Acta, 1529, 231-244.